Business intelligence reports for the lab diagnostics industry
Subscribe for Exclusive Access.
Subscriptions & Reports
![Mar2022-DTET-Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/Mar2022-DTET-Cover.webp)
![March2022-LCA.Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/March2022-LCA.Cover_.webp)
![March2022-LIR-Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/March2022-LIR-Cover.webp)
![April-2022-NLR-Briefing-Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/April-2022-NLR-Briefing-Cover.webp)
Interested in multiple copies or more than one of our G2 reports?
Call Sokha at 855-528-6903 or email spearson@g2intelligence.com to discuss pricing.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
U.S. Supreme Court Upholds Nationwide Individual Insurance Subsidies
By Ron Shinkman, Editor, Laboratory Industry Report The United States Supreme Court ruled Thursday to maintain income-based subsidies that allow millions of Americans to purchase individual health insurance policies from the federal healthcare.gov insurance...
Compliance Officers Need Increased Role in Strategic Decisionmaking
By Kelly A. Briganti, Editorial Director, G2 Intelligence PricewaterhouseCoopers (PwC) announced its fifth annual State of Compliance Survey (2015) indicates corporate compliance officers (CCOs) need to be more involved in strategic decisionmaking—as only one-third...
NCI-MATCH to Launch Simultaneous Trials of 20+ Targeted Therapies
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies The precision medicine trial NCI-MATCH (National Cancer Institute-Molecular Analysis for Therapy Choice) will open for patient enrollment in July. The multicenter trial will evaluate the...
Novel Marker Shows Promise for Early Detection of Pancreatic Cancer
By Stephanie Murg, Managing Director, G2 Intelligence Tiny particles known as exosomes may be a powerful cancer screening and diagnostic tool—the trick is detecting and isolating those that are derived from cancer cells. Researchers at the University of Texas MD...
ABIM Grant Awarded to Reduce Unnecessary Pap Tests
By Kelly A. Briganti, Editorial Director, G2 Intelligence In keeping with the national focus on reducing unnecessary medical care and getting the right test to the right patient at the right time, the American Board of Internal Medicine (ABIM) Foundation awarded a...